Home
Anders Engeland's picture
Photo:
Privat
  • E-mailAnders.Engeland@uib.no
  • Phone+47 55 58 61 27+47 970 18 094
  • Visitor Address
    Alrek helseklynge, blokk D, Årstadveien 17
  • Postal Address
    Postboks 7804
    5020 Bergen

Pharmacoepidemiology

Cancerepidemiology

  • Teacher at courses in Epidemiology for medical- and PhD-students
  • Supervisor for medical- and PhD-students
  • Show author(s) 2021. The Norwegian Society for Pharmacoepidemiology. Norsk Epidemiologi. 5-6.
  • Show author(s) 2021. Prescribed drugs in 27 000 individuals after diagnosis of colorectal cancer: A population-based cohort study. Pharmacoepidemiology and Drug Safety. 1037-1048.
  • Show author(s) 2021. Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project. International Journal of Cancer. 1-9.
  • Show author(s) 2021. Male to female ratios in autism spectrum disorders by age, intellectual disability and attention-deficit/hyperactivity disorder. Acta Psychiatrica Scandinavica. 1-12.
  • Show author(s) 2020. Validation of assisted reproductive technology in the Medical Birth Registry of Norway versus the Norwegian Prescription Database. Epidemiology. 681-686.
  • Show author(s) 2020. Urinary incontinence associated with anxiety and depression: the impact of psychotropic drugs in a cross-sectional study from the Norwegian HUNT study. BMC Psychiatry. 1-10.
  • Show author(s) 2020. Sex differences in parent–offspring recurrence of attention-deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry. 1-9.
  • Show author(s) 2020. Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based study. British Journal of Cancer. 161-166.
  • Show author(s) 2020. Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study. The Lancet Diabetes and Endocrinology. 94-105.
  • Show author(s) 2020. Incidence of Malformations After Early Pregnancy Exposure to Modafinil in Sweden and Norway. Journal of the American Medical Association (JAMA). 895-896.
  • Show author(s) 2020. Cancer risk in individuals with major birth defects: large Nordic population based case-control study among children, adolescents, and adults. The BMJ. 14 pages.
  • Show author(s) 2020. Antipsychotic drug use in pregnancy: A multinational study from ten countries. Schizophrenia Research. 106-115.
  • Show author(s) 2019. The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers. International Journal of Epidemiology. 93-104.
  • Show author(s) 2019. Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway. Pharmacology Research & Perspectives. 1-10.
  • Show author(s) 2019. Patterns of psychiatric comorbidity and genetic correlations provide new insights into differences between attention-deficit/hyperactivity disorder and autism spectrum disorder. Biological Psychiatry. 46 pages.
  • Show author(s) 2019. Parent-offspring recurrence of attention-deficit/hyperactivity disorder.
  • Show author(s) 2019. Parent-offspring recurrence of ADHD.
  • Show author(s) 2019. Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individuals. International Journal of Cancer. 58-67.
  • Show author(s) 2019. Epilepsy and autoimmune diseases: Comorbidity in a national patient cohort. Seizure. 89-95.
  • Show author(s) 2019. BMI and weight changes and risk of obesity-related cancers: a pooled European cohort study. International Journal of Epidemiology. 1872-1885.
  • Show author(s) 2019. Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: A Nordic population-based case-control study. International Journal of Cancer. 1-10.
  • Show author(s) 2018. Urate and the risk of Parkinson's disease in men and women. Parkinsonism & Related Disorders. 76-82.
  • Show author(s) 2018. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. Pharmacoepidemiology and Drug Safety. 995-1004.
  • Show author(s) 2018. Psychiatric comorbidity and genetic correlations provide new insights into differences between ADHD and autism .
  • Show author(s) 2018. Psychiatric comorbidity and genetic correlations provide new insights into differences between ADHD and autism .
  • Show author(s) 2018. Psychiatric comorbidities in adults with ADHD and/or autism: Can patterns of comorbidities together with genetics add knowledge on etiologic relations? .
  • Show author(s) 2018. Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women. International Journal of Cancer. 1858-1867.
  • Show author(s) 2018. Pregnancy complications and subsequent breast cancer risk in the mother: a Nordic population-based case-control study. International Journal of Cancer. 1904-1913.
  • Show author(s) 2018. Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death. Journal of the American Medical Association (JAMA). 2333-2335.
  • Show author(s) 2018. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. Addiction. 1286-1294.
  • Show author(s) 2018. Diabetes is associated with decreased migraine risk: A nationwide cohort study. Cephalalgia. 1759-1764.
  • Show author(s) 2018. Beta-blocker use in pregnancy and the risk of congenital malformations: An international cohort study. Annals of Internal Medicine. 665-673.
  • Show author(s) 2017. beta(2)-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson's disease. Science. 891-897.
  • Show author(s) 2017. The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures. European Journal of Clinical Pharmacology. 513-520.
  • Show author(s) 2017. Psychiatric comorbidities in male and female adults with ADHD.
  • Show author(s) 2017. Preterm births and use of medication in early adulthood: a population-based registry study. Pharmacoepidemiology and Drug Safety. 742-751.
  • Show author(s) 2017. OMT or drug abuse during pregnancy - does it affect the offspring? Results from Nationwide registry studies in the Czech Republic and Norway.
  • Show author(s) 2017. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study. The BMJ. 8 pages.
  • Show author(s) 2017. Neonatal Outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
  • Show author(s) 2017. Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder. Acta Psychiatrica Scandinavica. 176-186.
  • Show author(s) 2017. Gender Differences in Psychiatric Comorbidity: A Population-based Study of 40,000 Adults with Attention-Deficit/Hyperactivity Disorder.
  • Show author(s) 2017. Correction to: Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study. European Child and Adolescent Psychiatry. 1-1.
  • Show author(s) 2017. Condition of newborns of women received OMT and opiates during pregnancy: comparison of Czech and Norwegian cohorts.
  • Show author(s) 2017. Cohort Profile Update: The Janus Serum Bank Cohort in Norway. International Journal of Epidemiology. 1101-1102f.
  • Show author(s) 2017. Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases. Biological Psychiatry. 452-459.
  • Show author(s) 2017. Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study. European Child and Adolescent Psychiatry. 1-13.
  • Show author(s) 2017. Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: A cohort study from the international pregnancy safety study consortium. JAMA psychiatry. 167-175.
  • Show author(s) 2016. Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants in pregnancy and congenital anomalies: Analysis of linked databases in Wales, Norway and Funen, Denmark. PLOS ONE. 26 pages.
  • Show author(s) 2016. Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy – a cohort linkage study. BJOG: An International Journal of Obstetrics and Gynaecology. 1609-1618.
  • Show author(s) 2016. Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case–control study. British Journal of Cancer. 1416-1420.
  • Show author(s) 2016. Psychotropic Drug Exposure and Hip Fractures.
  • Show author(s) 2016. Prescribing of antidiabetic medicines before, during and after pregnancy: A study in seven European regions. PLOS ONE. 17 pages.
  • Show author(s) 2016. Pre-eclampsia and childhood asthma. European Respiratory Journal. 1622-1630.
  • Show author(s) 2016. Educational attainment among long-term survivors of cancer in childhood and adolescence: a Norwegian population-based cohort study. Journal of cancer survivorship. 87-95.
  • Show author(s) 2016. Does the choice of antiepileptic drug affect survival in glioblastoma patients? Journal of Neuro-Oncology. 461-469.
  • Show author(s) 2016. Asthma medication prescribing before, during and after pregnancy: a study in seven European regions. BMJ Open. 13 pages.
  • Show author(s) 2016. Antipsychotic drugs and risk of hip fracture among people older than 60 years in Norway. Journal of The American Geriatrics Society. 1203-1209.
  • Show author(s) 2015. Use of antidepressants and association with elective termination of pregnancy: population based case-control study. BJOG: An International Journal of Obstetrics and Gynaecology. 1618-1624.
  • Show author(s) 2015. Social inequalities and smoking-associated breast cancer - Results from a prospective cohort study. Preventive Medicine. 125-129.
  • Show author(s) 2015. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: Population based cohort study and sibling design. The BMJ.
  • Show author(s) 2015. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study. BMC Geriatrics. 1-10.
  • Show author(s) 2015. Preeclampsia in pregnancy and later use of antihypertensive drugs. European Journal of Epidemiology (EJE). 501-508.
  • Show author(s) 2015. Metabolic risk score and cancer risk: pooled analysis of seven cohorts. International Journal of Epidemiology. 1353-1363.
  • Show author(s) 2015. Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions. Pharmacoepidemiology and Drug Safety. 1144-1154.
  • Show author(s) 2014. Total drug treatment and comorbidity in myasthenia gravis: A population-based cohort study. European Journal of Neurology. 948-955.
  • Show author(s) 2014. The Association between Lifetime Smoking Exposure and Breast Cancer Mortality – Results from a Norwegian Cohort. Cancer Medicine. 1448-1457.
  • Show author(s) 2014. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. European Journal of Clinical Pharmacology. 873-880.
  • Show author(s) 2014. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a 6-year follow-up study based on nationwide registries.
  • Show author(s) 2014. Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations. Epidemiology. 823-828.
  • Show author(s) 2014. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes and Control. 151-159.
  • Show author(s) 2014. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurologica Scandinavica. 26-31.
  • Show author(s) 2014. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: A prospective study of 580 000 subjects within the Me-Can project. BMC Cancer. 12 pages.
  • Show author(s) 2014. Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation. Acta Obstetricia et Gynecologica Scandinavica. 647-653.
  • Show author(s) 2014. Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study. European Journal of Clinical Pharmacology. 1367-1374.
  • Show author(s) 2014. Associations between hip fractures & psychotropic drugs - a Nationwide prospective cohort study.
  • Show author(s) 2014. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLOS ONE.
  • Show author(s) 2013. Total serum cholesterol and cancer incidence in the Metabolic Syndrome and Cancer Project (Me-Can). PLOS ONE. 8 pages.
  • Show author(s) 2013. Smoking duration before first childbirth: an emerging risk factor for breast cancer? Results from 302,865 Norwegian women. Cancer Causes and Control. 1347-1356.
  • Show author(s) 2013. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. Journal of the American Medical Association (JAMA). 48-54.
  • Show author(s) 2013. Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination. New England Journal of Medicine. 333-340.
  • Show author(s) 2013. Risk of Fetal Death After Pandemic Influenza Virus Infection or Vaccination EDITORIAL COMMENT. Obstetrical and Gynecological Survey. 348-349.
  • Show author(s) 2013. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes and Control. 107-116.
  • Show author(s) 2013. Prescription drug use among pregnant women in opioid Maintenance Treatment. Addiction. 367-376.
  • Show author(s) 2013. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes and Control. 151-159.
  • Show author(s) 2013. Metabolic Factors Associated with Risk of Renal Cell Carcinoma. PLOS ONE.
  • Show author(s) 2013. Increased uptake of social security benefits among long-term survivors of cancer in childhood, adolescence and young adulthood: a Norwegian population-based cohort study. British Journal of Cancer. 1525-1533.
  • Show author(s) 2013. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry. Age and Ageing. 514-520.
  • Show author(s) 2013. Fetal growth and childhood cancer: A population-based study. Pediatrics. E1265-E1275.
  • Show author(s) 2013. Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340,000 pregnancies using Norwegian population-based databases. British Journal of Clinical Pharmacology. 1134-1141.
  • Show author(s) 2012. The 2009 Influenza Pandemic, Vaccination during Pregnancy and Fetal Death: A National Registry-Based Study in Norway. Pharmacoepidemiology and Drug Safety. 382-382.
  • Show author(s) 2012. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ. British Medical Journal. 9 pages.
  • Show author(s) 2012. Prospective study on metabolic factors and risk of prostate cancer. Cancer. 6199-6206.
  • Show author(s) 2012. Prescription Drug Use among Pregnant Women in Opioid Maintenance Treatment. Pharmacoepidemiology and Drug Safety. 388-388.
  • Show author(s) 2012. Prescribing quality for older people in Norwegian nursing homes and home nursing services using multidose dispensed drugs. Pharmacoepidemiology and Drug Safety. 929-936.
  • Show author(s) 2012. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150 000 pregnant women and expectant fathers. Scandinavian Journal of Rheumatology. 196-201.
  • Show author(s) 2012. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can). British Journal of Dermatology. 59-67.
  • Show author(s) 2012. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. International Journal of Cancer. 193-200.
  • Show author(s) 2012. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). Gynecologic Oncology. 330-335.
  • Show author(s) 2012. Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). Annals of Hematology. 1519-1531.
  • Show author(s) 2012. Inappropriate prescribing for older people admitted to an intermediate-care nursing home unit and hospital wards. Scandinavian Journal of Primary Health Care. 169-175.
  • Show author(s) 2012. Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential. Clinical Pharmacology and Therapeutics. 438-441.
  • Show author(s) 2012. Co-prescription of medication for bipolar disorder and diabetes mellitus: A nationwide population-based study. BMC Medicine. 6 pages.
  • Show author(s) 2012. Blood pressure and risk of cancer incidence and mortality in the Metabolic syndrome and cancer project. Hypertension. 802-810.
  • Show author(s) 2012. Blood pressure and other metabolic syndrome factors and risk of brain tumor in the large population-based Me-Can cohort study. Journal of Hypertension. 290-296.
  • Show author(s) 2012. An increased risk of motor vehicle accidents after prescription of methadone. Addiction. 967-972.
  • Show author(s) 2011. Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study. European Journal of Clinical Pharmacology. 953-960.
  • Show author(s) 2011. Use of Legally Prescribed Opioid Analgesics in Pregnant Women and Risk of Spontaneous Preterm Birth. A Population Based Cohort Study, Norway 2004-2008. Pharmacoepidemiology and Drug Safety. S75-S75.
  • Show author(s) 2011. USE OF PRESCRIBED DRUGS FOR THE NERVOUS SYSTEM AMONG WOMEN IN OPIOID MAINTENANCE TREATMENT BEFORE AND DURING PREGNANCY IN NORWAY, 2004-2008. Drug and Alcohol Review. 57-57.
  • Show author(s) 2011. Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes and Control. 291-299.
  • Show author(s) 2011. Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. European Journal of Epidemiology (EJE). 157-163.
  • Show author(s) 2011. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). International Journal of Cancer. 1890-1898.
  • Show author(s) 2011. Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can). Annals of Oncology. 1339-1345.
  • Show author(s) 2011. Metabolic risk factors and ovarian cancer in the Metabolic syndrome and cancer project. International Journal of Epidemiology. 1667-1677.
  • Show author(s) 2011. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes and Control. 743-751.
  • Show author(s) 2011. Metabolic Factors and the Risk of Colorectal Cancer in 580,000 Men and Women in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer. 2398-2407.
  • Show author(s) 2011. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiology and Drug Safety. 243-248.
  • Show author(s) 2011. An increased risk of road traffic accidents after prescriptions of methadone. Addiction.
  • Show author(s) 2010. Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. European Journal of Neurology. 1445-1450.
  • Show author(s) 2010. Metabolic syndrome and endometrial carcinoma. American Journal of Epidemiology. 892-902.
  • Show author(s) 2010. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiology, Biomarkers and Prevention. 1737-1745.
  • Show author(s) 2010. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Cancer Epidemiology, Biomarkers and Prevention. 2307-2317.
  • Show author(s) 2010. Does Pregabalin (Lyrica (R)) help patients reduce their use of Benzodiazepines? A comparison with gabapentin using the norwegian prescription database. Basic & Clinical Pharmacology & Toxicology. 883-886.
  • Show author(s) 2010. Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can). International Journal of Epidemiology. 660-667.
  • Show author(s) 2009. Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. Acta Obstetricia et Gynecologica Scandinavica. 1083-1089.
  • Show author(s) 2009. Use of opioids in mothers and fathers before and during pregnancy-2004-2006. Pharmacoepidemiology and Drug Safety. S71-S72.
  • Show author(s) 2009. Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study. Pharmacoepidemiology and Drug Safety. 737-742.
  • Show author(s) 2009. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007-A prescription database study. Journal of Affective Disorders. 208-211.
  • Show author(s) 2009. The risk of motor vehicle accidents involving drivers with prescriptions for codeine or tramadol. Clinical Pharmacology and Therapeutics. 596-599.
  • Show author(s) 2009. Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors. European Journal of Clinical Pharmacology. 295-301.
  • Show author(s) 2009. Road traffic accident risk in patients with diabetes mellitus receiving blood glucose-lowering drugs. Prospective follow-up study. Diabetic Medicine. 404-408.
  • Show author(s) 2009. Myasthenia gravis requiring drug treatment in a national population cohort. European Journal of Neurology. S207.
  • Show author(s) 2009. Fetal down syndrome and the risk of maternal breast cancer. Epidemiology. 584-589.
  • Show author(s) 2009. An increased risk of road traffic accidents after prescriptions of lithium or valproate? Pharmacoepidemiology and Drug Safety. 492-496.
  • Show author(s) 2008. Veitrafikkulykker knyttet til forskrivning av legemidler: En registerbasert kohortstudie. Norsk Epidemiologi. 159-165.
  • Show author(s) 2008. Use of antirheumatic drugs in mothers and fathers before and during pregnancy, 2004-2006. Pharmacoepidemiology and Drug Safety. S158.
  • Show author(s) 2008. Use of antirheumatic drugs in mothers and fathers before and during pregnancy. Annals of the Rheumatic Diseases. 581-581.
  • Show author(s) 2008. The use of lithium, valproate or lamotrigine as mood stabilizers in children and adolescents in Norway 2004-2007. Pharmacoepidemiology and Drug Safety. S90-S91.
  • Show author(s) 2008. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Medicine. 818-822.
  • Show author(s) 2008. Repeated dispensing of codeine is associated with high consumption of benzodiazepines. Norsk Epidemiologi. 185-190.
  • Show author(s) 2008. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004-2006. British Journal of Clinical Pharmacology. 653-660.
  • Show author(s) 2008. Patients treated with insulin or oral blood glucose lowering drugs and risk of road traffic accidents: A registry-based cohort study. Pharmacoepidemiology and Drug Safety. S190.
  • Show author(s) 2008. No increase in risk of road traffic accidents after prescriptions of mood stabilizers. Pharmacoepidemiology and Drug Safety. S19-S20.
  • Show author(s) 2008. Minor increase in risk of road traffic accidents after prescriptions of antidepressants: A study of population registry data in Norway. Journal of Clinical Psychiatry. 1099-1103.
  • Show author(s) 2008. Cohort Profile: Cohort of Norway (CONOR). International Journal of Epidemiology. 481-485.
  • Show author(s) 2008. Changes in physical activity behavior and the development of body mass index during the last 30 years in Norway. Scandinavian Journal of Medicine & Science in Sports. 309-317.
  • Show author(s) 2008. Cancer risk in children with birth defects and in their families: A population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiology, Biomarkers and Prevention. 500-506.
  • Show author(s) 2008. Body mass index in adolescence in relation to cause-specific mortality: A follow-up of 230,000 Norwegian adolescents. American Journal of Epidemiology. 30-37.
  • Show author(s) 2008. Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study. British Journal of Cancer. 1165-1169.
  • Show author(s) 2007. Veitrafikkulykker knyttet til forskrivning av legemidler: En registerbasert kohortstudie.
  • Show author(s) 2007. Use of stimulants for ADHD among children and adolescents in Norway: - a population based study 2004-2006.
  • Show author(s) 2007. Traffic accident risks associated with the prescription of medicinal drugs: A registry-based cohort study. Pharmacoepidemiology and Drug Safety. S12.
  • Show author(s) 2007. Traffic accident risk associated with the prescription of hypnotic drugs: a registry-based cohort study.
  • Show author(s) 2007. The risk of traffic accidents after prescriptions of carisoprodol. Accident Analysis and Prevention. 1050-1055.
  • Show author(s) 2007. Risk of road traffic accidents associated with the prescription of drugs: A registry-based cohort study. Annals of Epidemiology. 597-602.
  • Show author(s) 2007. Psychostimulant use among children and adolescents with ADHD in Norway: a population based study 2004-2006.
  • Show author(s) 2007. Psychostimulant use among children and adolescents with ADHD in Norway: A population based study 2004-2006. Pharmacoepidemiology and Drug Safety.
  • Show author(s) 2007. Prescription drug use before, during and after pregnancy among 50,000 women in Norway in 2004-2005. Pharmacoepidemiology and Drug Safety.
  • Show author(s) 2007. Prescription drug use before, during and after pregnancy among 50 000 women in Norway in 2004-2005.
  • Show author(s) 2007. Prescription drug use before, during and after pregnancy among 50 000 women in Norway in 2004-2005.
  • Show author(s) 2007. Medikamentbruk i forbindelse med svangerskap.
  • Show author(s) 2007. Medikamentbruk i forbindelse med svangerskap.
  • Show author(s) 2007. Height and body mass index and risk of lymphohematopoietic malignancies in two million norwegian men and women. American Journal of Epidemiology. 44-52.
  • Show author(s) 2007. Carisoprodol use and abuse in Norway. A pharmacoepidemiological study. British Journal of Clinical Pharmacology. 210-218.
  • Show author(s) 2007. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. International Journal of Cancer. 378-383.
  • Show author(s) 2007. Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study. BMC Clinical Pharmacology.
  • Show author(s) 2007. Antidepressiver hos barn og ungdom - førte advarsler til færre forskrivninger? Tidsskrift for Den norske legeforening. 2653-2655.
  • Show author(s) 2007. Age- and gender-specific antibacterial prescribing in Norway. Journal of Antimicrobial Chemotherapy. 971-976.
  • Show author(s) 2006. The prevalence and incidence of drug treated bipolar disorder in the adult(20-65 years) as seen in the Norwegian prescription database.
  • Show author(s) 2006. The prevalence and incidence of drug treated bipolar disorder in the adult(20-65 years) as seen in the Norwegian prescription database.
  • Show author(s) 2006. The pharmacoepidemiology of carisoprodol misuse and abuse.
  • Show author(s) 2006. The pharmacoepidemiology of Carisoprodol misuse and abuse. Pharmacoepidemiology and Drug Safety. S112-S113.
  • Show author(s) 2006. The impact of medicinal authority's warnings on the prescribing of SSRI antidepressants to children and adolescents in Norway. Pharmacoepidemiology and Drug Safety. S211-S211.
  • Show author(s) 2006. The impact of height and body mass index on the risk of testicular cancer in 600,000 Norwegian men. Cancer Causes and Control. 983-987.
  • Show author(s) 2006. The impact of body mass index on later total hip arthroplasty for primary osteoarthritis - A cohort study in 1.2 million persons. Arthritis and Rheumatism. 802-807.
  • Show author(s) 2006. The Impact of Medicinal Authority's Warnings on the Prescribing of SSRI Antidepressants to Children and Adolescents in Norway.
  • Show author(s) 2006. Hvor mange og hvem behandles medikamentelt for diabetes mellitus? Tidsskrift for Den norske legeforening. 768-770.
  • Show author(s) 2006. How many and who are receiving medication for treatment of diabetes mellitus in Norway? Pharmacoepidemiology and Drug Safety. S162-S162.
  • Show author(s) 2006. How many and who are receiving medication for treatment of diabetes mellitus in Norway?
  • Show author(s) 2006. Endringer i salg og bruk av flunitrazepam etter 1999. Tidsskrift for Den norske legeforening. 589-590.
  • Show author(s) 2006. Comparison of statin use in three Norwegian counties in 2004- an individualised prescription database study.
  • Show author(s) 2006. Comparison of statin use in three Norwegian counties in 2004 - An individualised prescription database study. Pharmacoepidemiology and Drug Safety. S256-S256.
  • Show author(s) 2006. Body size and thyroid cancer in two million Norwegian men and women. British Journal of Cancer. 366-370.
  • Show author(s) 2006. Age and sex specific antibacterial prescribing in Norway. Pharmacoepidemiology and Drug Safety. S69-S69.
  • Show author(s) 2005. The Norwegian prescription database(NorPD)-a new register for pharmacoepidemiologic research covering a whole nation.
  • Show author(s) 2005. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes and Control. 987-996.
  • Show author(s) 2005. Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. British Journal of Cancer. 807-810.
  • Show author(s) 2005. Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. British Journal of Cancer. 807-810.
  • Show author(s) 2005. Do variations in sales of lipid-lowering drugs reflect true prevalences of use?A prescription database study of lipid-lowering drugs in regions with high (Hedmark), average (Oppland) and low (Troms) total sales.
  • Show author(s) 2004. Relation of Height and Body Mass Index to Renal Cell Carcinoma in Two Million Norwegian Men and Women. American Journal of Epidemiology. 1168-1176.
  • Show author(s) 2004. Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology. 79-85.
  • Show author(s) 2004. Body mass index in relation to adult asthma among 135,000 Norwegian men and women. American Journal of Epidemiology. 169-976.
  • Show author(s) 2003. Height, body mass index and prostate cancer: a follow-up of 950 000 Norwegian men. British Journal of Cancer. 1237-1242.
  • Show author(s) 2003. Height, body mass index and ovarian cancer: a follow-up of 1.1 million Norwegian women. Journal of the National Cancer Institute. 1244-1248.
  • Show author(s) 2003. Er det forskjeller i forekomst av underarmsbrudd mellom by og land i Norge? Data fra CONOR.
  • Show author(s) 2003. CONOR (Cohort NORway) - en oversikt over en unik forskningdata. Norsk Epidemiologi. 72-77.
  • Show author(s) 2003. Body mass index in adolescence in relation to total mortality: 32 year follow-up 227, Norwegian and girls. American Journal of Epidemiology. 517-523.
  • Show author(s) 2003. A height and body mass index in relation to total mortality. Epidemiology. 293-299.
  • Show author(s) 2002. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. British Journal of Cancer. 61-64.
  • Show author(s) 2002. Effects of first aid training in junior high schools. Injury control and safety promotion. 99-106.
  • Show author(s) 2002. Bruk av p-piller og risiko for kreft. Tidsskrift for Den norske legeforening. 1788-1790.

More information in national current research information system (CRIStin)

List of publications in peer-reviewed journals

1. Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, Magnus K, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P. Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic cancer registries. APMIS Suppl 1993; 38: 1–124.

2. Paus E, Theodorsen L, Engeland A. Prostate-specific antigen in serum from blood donors with subsequent cancer prostate diagnosis. Eur J Can­cer 1993, 29A, 1221–2.

3. Magnus K, Engeland A, Green BMR, Haldorsen T, Muirhead CR, Strand T. Residential radon exposure and lung cancer. An epidemiological study of Norwegian municipalities. Int J Cancer 1994; 58: 1–7.

4. Grøndahl AM, Gaustad G, Engeland A. Progression and association with lameness and racing performance of radiographic changes in the proximal sesamoid bones of young standardbred trotters Equine Vet J 1994; 26: 152–5. 

5. Engeland A, Haldorsen T, Tretli S. [Prediction of cancer mortality based on relative survival analysis] Prediksjon av kreftdødelighet basert på relativ overlevelsesanalyse. Nor Epidemiol 1994; 4: 82–5. 

6. Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P. Prediction of cancer mortality in the Nordic countries up to the Years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic cancer registries. APMIS Supplement 1995; 49: 1–163.

7. Grøndahl AM, Engeland A. Influence of radiographically orthopedic changes on racing performance in Standardbred trotters. J Am Vet Med Ass 1995; 206: 1013-7.

8. Tretli S, Engeland A, Haldorsen T, Hakulinen T, Hörte LG, Luostarinen T, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P. Prostate cancer–Look to Denmark? Letter. J Natl Cancer Inst 1996; 88: 128.

9 . Engeland A, Haldorsen T, Andersen A, Tretli S. The impact of smoking habits on lung cancer risk: 28 years’ observation of 26,000 Norwegian men and women. Cancer Causes Control 1996; 7: 366–76.

10 . Engeland A, Andersen A, Haldorsen T, Tretli S. Smoking habits and risk of cancers other than lung cancer: 28 years’ follow-up of 26,000 Norwegian men and women. Cancer Causes Control 1996; 7: 497–506.

11. Andersen A, Berge SR, Engeland A, Norseth T. Exposure to nickel com­pounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery work­ers. Occup Env Med. 1996; 53: 708–13.

12 . Engeland A. Trends in the incidence of smoking-associated cancers in Norway, 1954–93. Int J Cancer 1996; 68: 39–46.

13 . Engeland A, Bjørge T, Haldorsen T, Tretli S. Use of multiple primary cancers to indicate associations between smoking and cancer incidence. An analysis of 500,000 cancer cases diagnosed in Norway during 1953–93. Int J Cancer 1997; 70: 401-7.

14. Hafstad A, Aarø LE, Engeland A, Andersen A, Langmark F, Stray-Pedersen B. Provocative appeals in anti-smoking mass media campaigns targeting adolescent - the accumulated effect of multiple exposures. Health Education Research 1997; 12: 227-36.

15. Bjørge T, Engeland A, Hansen S, Tropé C. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954–93. Int J Cancer 1997; 71: 780-6.

16. Bjørge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Youngman L, Thoresen S. A prospective, seroepidemiological study of the role of human papillomavirus in non-cervical anogenital cancers. BMJ 1997; 315: 346-9.

17. Bjørge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, Luostarinen T, Paavonen J, Sapp M, Schiller J, Thoresen S, Wang Z, Youngman L, Dillner J. Prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res 1997; 57: 3989-92.

18. Daae LNW, Engeland A, Freng A. [Experiences from serum protein investigations in patients with recently discovered malignant tumors in the upper digestive tract] Serumproteiner hos pasienter med nyoppdaget kreft i munn­hule/svelg. Hvilken lærdom gav konsentrasjonsmåling og elektroforese? Tidsskr Nor Laegeforen 1997; 117: 3671-3.

19. Engeland A, Bjørge T, Haldorsen T, Tretli S. Prognosis of patients with lung cancer diagnosed in Norway, 1954-1993. Cancer Causes Control 1998; 9: 57-65.

20 . Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Möller TR, Storm HH, Tulinius H. Relative survival of cancer patients. A comparison between Denmark and the other Nordic countries. Acta Oncol 1998; 37: 49-59.

21. Bjørge T, Engeland A, Hansen S, Tropé CG. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993. Int J Cancer 1998; 75: 663-70.

22. Freng A, Daae LNW, Engeland A, Norum KR, Sander J, Solvoll K, Tretli S. Malignant epithelial tumours in the upper digestive tract: a dietary and socio-medical case-control and survival study. Eur J Clin Nutr 1998; 52: 271-8.

23. Engeland A, Bjørge T. [Passive smoking and risk of cancer] Passiv røyking og kreftrisiko. Tidsskr Nor Laegeforen 1998; 118: 2183-6.

24. Bjørge T, Engeland A, Hansen S, Tropé CG. [Ovarian cancer and borderline tumours.] Ovarialcancer og borderlinetumorer. Tidsskr Nor Laegeforen 1998; 118: 2471-5.

25. Grimsrud TK, Langseth H, Engeland A, Andersen A. Lung and bladder cancer in a Norwegian municipality with iron and steel producing industry: population based case-control studies. Occup Env Med 1998; 55: 387-92.

26. Bjørge T, Engeland A, Sundfør K, Tropé CG. Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital. Acta Obstet Gynecol Scand 1998; 77: 777-81.

27. Storm HH, Dickman PW, Engeland A, Haldorsen T, Hakulinen T. Do morphology and stage explain the inferior lung cancer survival in Denmark? Eur Respir J. 1999; 13: 430-5.

28. Engeland A, Kopjar B. [Injuries among children] Skader blant barn behandlet ved legevakt og i sykehus 1990-97. Tidsskr Nor Laegeforen 1999; 119: 784-7.

29. Berg JP, Engeland A, Jellum E, Glattre E. Serum dehydroepiandrosterone sulfate concentration and thyroid cancer risk: a matched case-control study. Thyroid 1999; 9: 285-8.

30. Bjørge T, Tropé CG, Engeland A. [Screening for cancer] Screening mot kreft. Tidsskr Nor Laegeforen 1999; 119: 1129-36.

31. Andersen A, Barlow L, Engeland A, Kjærheim K, Lynge E, Pukkala E. Work-related cancer in the Nordic countries. Scand J Work Environ Health 1999; 25 suppl 2: 1-116.

32. Engeland A, Kopjar B. [Injuries from violence in Norway - analysis of the data from the Norwegian National Injury Sample Registry] Voldsskader i Norge - en analyse av data fra personskaderegisteret. Tidsskr Nor Laegeforen 2000; 120: 714-7.

33. Kopjar B, Engeland A, Bjørndal A. Impact of the Safe Community program in Harstad on the incidence of injuries. Injury Control Saf Promotion 2000; 7: 29-39.

34. Myklestad I, Engeland A. . [Product-related home injuries among pre-school children] Hjemmeulykker blant småbarn og potensiale for forebygging. Tidsskr Nor Laegeforen 2000; 120: 3376-9.

35. Sjølingstad A, Alvær K, Engeland A, Forsén L. [Registration of external causes of injuruy by ICD-10 in Norwegian hospitals] Skaderegistrering ved hjelp av ICD-10 ved norske sykehus. Tidsskr Nor Laegeforen 2001; 121: 1052-4.

36. Engeland A, Wiik J, Lande G. [Registration of parasuicide at hospitals and emergency wards] Registrering av parasuicid ved sykehus og legevakt. Tidsskr Nor Laegeforen 2001; 121: 1033-7.

37. Glattre E, Engeland A, Jellum E, Høstmark AT. Serum-albumin and risk of thyroid cancer: A population-based, matched case-control study. Nor Epidemiol 2001; 11: 197-200.

38. Bjørge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E, Thoresen SØ, Dillner J. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 2002; 87: 61-4. Erratum in Br J Cancer 2004; 91: 1226.

39. Bjørge T, Engeland A. [P-pills and risk of cancer] Bruk av p-piller og risiko for kreft. Tidsskr Nor Laegeforen 2002; 122: 1788-90.

40. Engeland A, Røysamb E, Smedslund G, Søgaard AJ. Effects of first-aid training in junior high schools. Injury Control Saf Promotion 2002; 9: 99-106.

41 . Engeland A, Bjørge T, Søgaard AJ, Tverdal A. Body mass index in adolescence in relation to total mortality: 32-year follow-up of 227,000 Norwegian boys and girls. Am J Epidemiol 2003; 157: 517-23.

42. Engeland A, Bjørge T, Selmer RM, Tverdal A. Height and body mass index in relation to total mortality. Epidemiology 2003; 14: 293-9.

43. Engeland A, Tretli S, Bjørge T. Height, body mass index, and ovarian cancer: A follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 2003: 95: 1244-8.

44. Engeland A, Søgaard AJ. [CONOR (COhort NORway) - an overview of a unique research material] CONOR (COhort NORway) - en oversikt over en unik forskningsdatabank. Nor Epidemiol 2003; 13: 73-7.

45. Engeland A, Tretli S, Bjørge T. Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men. Br J Cancer 2003; 89: 1237-42.

46. Engeland A, Bjørge T, Tverdal A, Søgaard AJ. Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology 2004; 15: 79-85.

47. Engeland A, Bjørge T, Tretli S. Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and women. Cancer Causes Control 2004; 15: 837-43.

48. Nystad W, Meyer HE, Nafstad P, Tverdal A, Engeland A. Body mass index in relation to adult asthma among 135,000 Norwegian men and women. Am J Epidemiol 2004; 160: 969-76.

49. Bjørge T, Tretli S, Engeland A. Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 2004; 160: 1168-76.

50. Engeland A, Tretli S, Austad G, Bjørge T. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control 2005; 16: 987-96.

51. Bjørge T, Tretli S, Engeland A. Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. Br J Cancer 2005; 93: 807-10.

52. Flugsrud GB, Nordsletten L, Espehaug B, Havelin LI, Engeland A, Meyer HE. The impact of BMI on later total hip arthroplasty due to primary osteoarthritis. A cohort study in 1.2 million persons. Arthritis Rheum 2006; 54: 802-7.

53. Bramness JG, Skurtveit S, Furu K, Engeland A, Sakshaug S, Rønning M. Endringer i salg og bruk av flunitrazepam i perioden 1999-2004. [Changes in the sale and use of flunitrazepam in Norway, 1999 - 2004.] Tidsskr Nor Laegeforen 2006; 126: 589-90.

54. Strøm H, Engeland A, Eriksen E, Rønning M. [How many and who are receiving medication for treatment of diabetes mellitus in Norway?] Hvor mange og hvem (alder og kjønn) behandles medikamentelt for diabetes mellitus i Norge? Tidsskr Nor Laegeforen  2006; 126: 768–70.

55. Bjørge T, Tretli S, Lie AK, Engeland A. The impact of height and body mass index on the risk of testicular cancer in 600,000 Norwegian men. Cancer Causes Control 2006; 17: 983-7.

56. Engeland A , Tretli S, Akslen LA, Bjørge T. Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer 2006; 95: 366-70.

57. Bjørge T, Engeland A, Tretli S, Weiderpass E. Body mass size in relation to cancer of the uterine corpus in one million Norwegian women. Int J Cancer 2007; 120, 378–83.

58. Engeland A, Tretli S, Hansen S, Bjørge T. Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol 2007; 165: 44-52.

59. Bramness JG, Furu K, Engeland A, Skurtveit S. Carisoprodol use and abuse – a pharmacoepidemiological study. Br J Clin Pharmaco 2007; 64: 210-8.

60. Blix HS, Engeland A, Litleskare I, Rønning M. Age and gender -specific antibacterial prescribing in Norway. J Antimicr Chem 2007; 59:971-6.

61. Bramness JG, Skurtveit S, Mørland J, Engeland A. The risk of traffic accidents after prescriptions of carisoprodol. Accid Anal Prev 2007; 39:1050-55.

62. Engeland A, Skurtveit S, Mørland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol. 2007, 17: 597-602.

63. Anderssen SA, Engeland A, Søgaard AJ, Nystad W, Graff-Iversen S, Holme I. Changes in physical activity behavior and the development of body mass index during the last 30 years in Norway. Scand J Med Sci Sports 2008; 18: 309-17.

64. Bramness JG, Engeland A, Furu K. Antidepressiver hos barn og ungdom – førte advarsler til færre forskrivninger? [Use of antidepressants among children and adolescents - did the warnings lead to fewer prescriptions?] Tidsskr Nor Laegeforen  2007; 127: 2653–5.

65. Næss Ø, Søgaard AJ, Arnesen E, Beckstrøm AC, Bjertness E, Engeland A, Hjort PF, Holmen J, Magnus P, Njølstad I, Tell GS, Vatten L, Vollset SE, Aamodt G. Cohort Profile: Cohort of Norway (CONOR). Int J Epidemiol 2008; 37: 481-5.

66. Hartz I, Sakshaug S, Furu K, Engeland A, Eggen AE, Njølstad I, Skurtveit S. Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study. BMC Clin Pharmacol 2007; 7: 14.

67. Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel CI, Mørland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008; 9: 818-22.

68. Engeland A, Bramness JG, Daltveit AK, Rønning M, Skurtveit S, Furu K. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-06. Br J Clin Pharmaco 2008; 69: 653-60.

69. Bjørge T, Cnattingius S, Lie RT, Tretli S, Engeland A. Cancer risk in children with birth defects and in their families. A population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiol Biomarkers Prev 2008: 17: 500-6.

70. Bjørge T, Engeland A, Tverdal A, Davey Smith G. Body mass index in adolescence in relation to cause-specific mortality: A follow-up of 230,000 Norwegian adolescents. Am J Epidemiol 2008; 168: 30-7.

71. Engeland A, Bramness JG, Mørland J, Skurtveit S. Veitrafikkulykker knyttet til forskrivning av legemidler: En registerbasert kohortstudie. [Traffic accident risks associated with the prescription of medicinal drugs: a registry-based cohort study.] Nor Epidemiol 2008; 18: 159-65. http://www.ub.ntnu.no/journals/norepid/2008-2.html.

72. Bachs LC, Bramness JG, Engeland A, Skurtveit S. Repeated dispensing of codeine is associated with high consumption of benzodiazepines. Nor Epidemiol 2008; 18; 185-90. http://www.ub.ntnu.no/journals/norepid/2008-2.html.

73. Bramness JG, Skurtveit S, Neutel CI, Mørland J, Engeland A. Minor increase in risk of road traffic accidents after prescriptions of antidepressants: A study of population registry data in Norway.  J Clin Psychiat 2008; 69: 1099-103.

74. Bjørge T, Engeland A, Tretli S, Heuch I. Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study.  Br J Cancer 2008; 99: 1165-9.

75. Hausken AM, Furu K, Skurtveit S, Engeland A, Bramness JG. Starting insomnia treatment: The use of benzodiazepines versus z-hypnotics.A prescription database study of predictors. Eur J Clin Pharmacol 2009; 65: 295-301.

76. Bramness JG, Grøholt B, Engeland A, Furu K. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study. J Affect Disord. 2009; 117: 208-11.

77. Bachs L, Engeland A, Mørland J, Skurtveit S. The Risk of Motor Vehicle Accidents Involving Drivers With Prescriptions for Codeine or Tramadol. Clin Pharmacol Ther 2009; 85: 596-9.

78. Skurtveit S, Strøm H, Skrivarhaug T, Mørland J, Bramness JG, Engeland A. Road traffic accident risk in patients with diabetes mellitus, receiving blood glucose-lowering drugs. Prospective follow-up study. Diabetic Med 2009; 26: 404-8.

79. Bramness JG, Skurtveit S, Neutel CI, Mørland J, Engeland A. An increased risk of road traffic accidents after prescriptions of lithium or valproate? Pharmacoepidemiol Drug Saf 2009; 18: 492-6.

80. Bjørge T, Cnattingius S, Engeland A, Tretli S, Lie RT, Lukanova A. Fetal Down syndrome and the risk of maternal breast cancer. Epidemiology 2009; 20: 584-89.

81. Viktil KK, Engeland A, Furu K. Use of antirheumatic drugs in mothers and fathers before and during pregnancy – a population based cohort study. Pharmacoepidemiol Drug Saf 2009: 18: 737-42.

82. Engeland A, Bjørge T, Daltveit AK, Vollset SE, Furu K. Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 2009; 88: 1083-9.

83. Stocks T, Borena W, Strohmaier S, Bjørge T, Manjer J, Engeland A, Johansen D, Selmer R, Hallmans G, Rapp K, Concin H, Jonsson H, Ulmer H, Stattin P. Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can). Int J Epidemiol 2010; 39: 660-7.

84. Bjørge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, Rapp K, Ulmer H, Almquist M, Concin H, Hallmans G, Jonsson H, Stattin P, Engeland A. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 2010; 171: 892-902.

85. Bramness JG, Sandvik P, Engeland A, Skurtveit S. Does pregabalin (Lyrica®) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database. Basic Clin Pharmacol 2010

86. Andersen JB, Engeland A, Owe JF, Gilhus NE. Myasthenia gravis requiring drug treatment in a national population cohort. Eur J Neurol 2010; 17: 1445-50.

87. Häggström C, Stocks T, Rapp K, Bjørge T, Lindkvist B, Concin H, Engeland A, Manjer J, Ulmer H, Selmer R, Tretli S, Hallmans G, Jonsson H, Stattin P. Metabolic syndrome and risk of Bladder cancer. Prospective cohort study in Metabolic syndrome and Cancer project (Me-Can). Int J Cancer 2010.

88. Bjørge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Häggström C, Stattin P, Engeland A. Metabolic syndrome and breast cancer in the Me-Can (Metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010; 19:1737-45.

89. Johansen D, Stocks T, Jonsson H, Lindkvist B, Bjørge T, Concin H, Almquist M, Häggström C, Engeland A, Ulmer H, Hallmans G, Selmer R, Nagel G, Tretli S, Stattin P, Manjer J.  Metabolic Factors and the Risk of Pancreatic cancer: A Prospective analysis of almost 600,000 men and women in the Me-Can project. Cancer Epidemiol Biomarkers Prev 2010; 19: 2307-17.

90. Nagel G, Concin H, Bjørge T, Rapp K, Manjer J, Hallmans G, Diem G , Häggström C, Engeland A, Almquist M, Jonsson H, Selmer R, Stocks T, Tretli S, Ulmer, Stattin P, Lukanova A. Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can). Ann Oncol 2010.

91. Borena W, Stocks T, Jonsson H, Strohmaier S, Nagel  G, Bjørge T,  Manjer J, Hallmans G, Selmer R, Almquist M, Häggstöm C, Engeland A, Tretli S, Concin H, Strasak A, Stattin P,Ulmer H. Serum triglycerides and cancer risk in the Me-Can Collaborative Study. Cancer Causes Control 2011; 22: 291-9.

92. Stocks T, Lukanova A,Bjørge T, Ulmer H, Manjer J, Almquist M, Concin H, Engeland A, Hallmans G, Nagel, Tretli S, Veierød MB, Jonsson H, Stattin P. Metabolic factors and risk of colorectal cancer in 580,000 men and women in the Metabolic syndrome and Cancer project (Me-Can): a pooled cohort study. Cancer 2010.

93. Espnes MG, Bjørge T, Engeland A. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf  2011; 20: 243-8.

94. Engeland A, Bjørge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, Furu K. Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. Eur J Epidemiol 2011; 26: 157-63.

95. Almquist M, Johansen D, Bjørge T, Ulmer H, Lindkvist B, Stocks T, Hallmans G, Engeland A, Rapp K, Jonsson H, Selmer R, Diem G, Häggström C, Tretli S, Stattin P, Manjer J. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can): a prospective analysis of 580,000 men and women. Cancer Causes Control 2011.

96. Handal M, Engeland A, Rønning M, Skurtveit S, Furu K. Use of prescribed opioid analgesic in women before, during and after pregnancy. A population based cohort study. Eur J Clin Pharm 2011.

 

  • Use of medication in connection with pregnancy
  • Risk of hip fracture associated with the prescription of drugs
  • Metabolic syndrome and cancer

  • Pregnancy conditions and birth characteristics in relation to cancer in childhood and adolescence

  • Risk of cancer in families of children with birth defects

MSc (Mathematical statistics)

PhD (Cancer epidemiology)

Research groups